Hydroxyzine is NOT appropriate for performance anxiety (public speaking)
Hydroxyzine should not be used for performance anxiety or public speaking situations because it causes significant cognitive impairment and sedation that would worsen performance, and it is not indicated for this specific condition. Beta-blockers (like propranolol) are the evidence-based choice for performance anxiety.
Why Hydroxyzine is Inappropriate for Performance Anxiety
Cognitive Impairment Profile
Hydroxyzine causes substantial performance degradation that directly contradicts the goals of public speaking:
- Morning doses produce severe impairment on divided attention tasks, reaction time, and attention switching—all critical for effective public speaking 1
- Driving impairment persists even after 8 days of treatment, indicating incomplete tolerance development 2
- The sedative effects are more pronounced after morning doses (when most public speaking occurs) compared to evening doses 1
Wrong Indication
- Hydroxyzine is studied and approved for generalized anxiety disorder (GAD), not performance/situational anxiety 3, 4
- GAD is characterized by chronic, persistent worry across multiple domains—fundamentally different from the acute, situational anxiety of public speaking
- The one study examining simulated public speaking used diazepam (a benzodiazepine), not hydroxyzine, showing this is the wrong drug class for this indication 5
Safety Concerns for This Use Case
The FDA label highlights critical warnings that make hydroxyzine particularly problematic for performance situations 6:
- QT prolongation risk with potential for Torsade de Pointes
- Potentiation of CNS depression requiring caution with any other sedating substances
- Explicit warning against operating dangerous machinery while taking hydroxyzine—public speaking requires sharp cognitive function
- Drowsiness is expected, not an occasional side effect
What Should Be Used Instead
Beta-blockers (propranolol 10-40 mg taken 30-60 minutes before speaking) are the evidence-based treatment for performance anxiety, targeting the peripheral manifestations (tremor, tachycardia, sweating) without causing cognitive impairment.
Common Pitfalls to Avoid
- Don't confuse GAD with performance anxiety: These are distinct conditions requiring different treatments
- Don't assume antihistamine sedation is "mild": Research demonstrates hydroxyzine causes impairment comparable to first-generation sedating antihistamines 1, 2
- Don't rely on tolerance development: Studies show impairment persists even after repeated dosing 2
If Hydroxyzine Were Considered Despite These Concerns
Should a clinician still consider hydroxyzine (which I strongly advise against for this indication), the dosing would theoretically be 6, 3:
- 12.5-25 mg taken the evening before (not morning of) the event
- However, even evening dosing shows residual morning impairment 7
- This approach still lacks evidence for performance anxiety specifically
The evidence clearly indicates hydroxyzine would impair rather than enhance public speaking performance.